Adenocarcinoma of the endometrium in women taking sequential oral contraceptives.

Abstract

Abnormal bleeding while taking oral steroidal contraceptives has been managed by changes in pill or addition of estrogen or progestin moieties. Diagnostic procedures, classically indicated, are universally not undertaken or postponed. Three cases of adenocarcinoma of the endometrium in relatively young patients using sequential oral contraceptives for cause are presented to reiterate the need for tissue diagnosis when abnormal bleeding occurs as a common side-effect of contraceptive therapy.

• Authors: H W Kelley, P A Miles, J E Buster, W H Scragg
• Journal: Obstetrics and gynecology (Obstet Gynecol) Vol. 47 Issue 2 Pg. 202-2 (Feb 1976) ISSN: 0029-7844 [Print] United States
• PMID: 1250543 (Publication Type: Case Reports, Journal Article)

Chemical References

• Contraceptives, Oral
• Contraceptives, Oral, Sequential

Topics

• Adenocarcinoma (chemically induced, pathology)
• Adult
• Contraceptives, Oral (adverse effects)
• Contraceptives, Oral, Sequential (adverse effects)
• Endometriosis (chemically induced, pathology)
• Female
• Humans
• Middle Aged
• Uterine Neoplasms (chemically induced, pathology)